Search | Page 11 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Iron overload in myelodysplastic syndromes: diagnosis and management.

    ... (RBC) transfusions for symptomatic management of refractory anemia . Iron overload ensues when the iron acquired ...

    Research Article last updated 10/11/2011 - 5:58pm.

  2. Resistance to Hypomethylating Agents in the Treatment of MDS

    ... What is the difference between MDS that is refractory to hypomethylating agents and recurrent MDS that returns after ... is important to identify what we mean when use the words ‘refractory’ and ‘resistant’. My view is that there is a difference, and ...

    Interview last updated 06/17/2014 - 9:15am.

  3. New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.

    ... severity of AA and to efficiently treat patients with refractory and relapsed AA. Immune-mediated AA was reproduced in animals, ...

    Research Article last updated 11/14/2013 - 11:18am.

  4. Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes.

    ... from phagocytosis in vitro. However, in the high-risk refractory anemia with excess blasts (RAEB) stages of MDS, ...

    Research Article last updated 03/05/2013 - 9:20am.

  5. Outcome of Allogeneic Stem Cell Transplantation for Patients Transformed to MDS or Leukemia from Severe Aplastic Anemia. A report by the MDS subcommittee of the chronic malignancies working party (CMWP) and the severe aplastic anemia working party (WPSAA)

    ... untreated or in remission than in patients with refractory disease. Allogeneic HSCT leads to prolonged survival in close ...

    Research Article last updated 06/19/2014 - 12:29pm.

  6. Pathogenesis of MDS: An Overview of molecular and non-molecular aspects of the disease

    ... of 4.5 months) especially for patients who fail ( refractory /relapsed) HMT. The only potential curative treatment for MDS is ...

    Research Article last updated 05/12/2015 - 9:47am.

  7. Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease

    ... of 4.5 months) especially for patients who fail ( refractory /relapsed) HMT. The only potential curative treatment for MDS is ...

    Research Article last updated 01/20/2015 - 12:52pm.

  8. Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C.

    ... of -7/del(7q), and French-American-British subtypes refractory anaemia with excess blasts (RAEB) and RAEB in ...

    Research Article last updated 10/11/2011 - 5:58pm.

  9. Management of acquired aplastic anemia in children

    ... agents provide multiple alternatives for treating refractory or relapsed patients. Regardless of the type of therapeutic ...

    Research Article last updated 02/04/2013 - 2:05pm.

  10. Neighborhood socioeconomic status influences the survival of elderly patients with myelodysplastic syndromes in the United States.

    ... of SES on survival was more apparent for patients with refractory anemia with ringed sideroblasts-patients residing in ...

    Research Article last updated 10/11/2011 - 5:58pm.